Vimarsana
Biggest News Aggregation in the World

Page 7 - Fda Clearance News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fda Clearance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fda Clearance Today - Breaking & Trending Today

FDA Clears TytoCare's New Algorithm for Wheeze Detection - Vimarsana News

FDA Clears TytoCare's New Algorithm for Wheeze Detection

Virtual care company TytoCare has received FDA clearance for its wheeze detection algorithm, allowing the company to begin commercializing the product in the U.S. The new algorithm is an expansion of Tyto Insights, the company's AI-powered diagnosis support software.

Rune Labs gets FDA clearance to use Apple Watch to track Parkinson's symptoms - Vimarsana News

Rune Labs gets FDA clearance to use Apple Watch to track Parkinson's symptoms

Rune Labs gets FDA clearance to use Apple Watch to track Parkinson's symptoms

Prostate Cancer Risk Test Gets FDA Clearance; 23andMe Reports New Test for Mutation - Vimarsana News

Prostate Cancer Risk Test Gets FDA Clearance; 23andMe Reports New Test for Mutation

Prostate Cancer Risk Test gets its awaited FDA clearance to see the new mutation that 23andMe and researchers discovered.

Accutar Biotechnology Announces FDA Clearance of IND Application for Phase 1 Trial of AC0176 in Prostate Cancer - Vimarsana News

Accutar Biotechnology Announces FDA Clearance of IND Application for Phase 1 Trial of AC0176 in Prostate Cancer

Accutar Biotechnology, Inc., a biotechnology company focusing on artificial intelligence (AI)-empowered drug discovery, today announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s investigational new drug application (IND) for AC0176 for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC).

Boasting reduced hospitalizations, Merck Covid pill awaits approval - Vimarsana News

Boasting reduced hospitalizations, Merck Covid pill awaits approval

Merck, the science and tech company, has urged regulatory agencies in the United States to grant authorization for use of its pill to treat Covid-19